Literature DB >> 11316879

Crystal structure of a deletion mutant of human thymidylate synthase Delta (7-29) and its ternary complex with Tomudex and dUMP.

R Almog1, C A Waddling, F Maley, G F Maley, P Van Roey.   

Abstract

The crystal structures of a deletion mutant of human thymidylate synthase (TS) and its ternary complex with dUMP and Tomudex have been determined at 2.0 A and 2.5 A resolution, respectively. The mutant TS, which lacks 23 residues near the amino terminus, is as active as the wild-type enzyme. The ternary complex is observed in the open conformation, similar to that of the free enzyme and to that of the ternary complex of rat TS with the same ligands. This is in contrast to Escherichia coli TS, where the ternary complex with Tomudex and dUMP is observed in the closed conformation. While the ligands interact with each other in identical fashion regardless of the enzyme conformation, they are displaced by about 1.0 A away from the catalytic cysteine in the open conformation. As a result, the covalent bond between the catalytic cysteine sulfhydryl and the base of dUMP, which is the first step in the reaction mechanism of TS and is observed in all ternary complexes of the E. coli enzyme, is not formed. This displacement results from differences in the interactions between Tomudex and the protein that are caused by differences in the environment of the glutamyl tail of the Tomudex molecule. Despite the absence of the closed conformation, Tomudex inhibits human TS ten-fold more strongly than E. coli TS. These results suggest that formation of a covalent bond between the catalytic cysteine and the substrate dUMP is not required for effective inhibition of human TS by cofactor analogs and could have implications for drug design by eliminating this as a condition for lead compounds.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11316879      PMCID: PMC2374201          DOI: 10.1110/ps.47601

Source DB:  PubMed          Journal:  Protein Sci        ISSN: 0961-8368            Impact factor:   6.725


  25 in total

1.  The CCP4 suite: programs for protein crystallography.

Authors: 
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  1994-09-01

2.  Structure, multiple site binding, and segmental accommodation in thymidylate synthase on binding dUMP and an anti-folate.

Authors:  W R Montfort; K M Perry; E B Fauman; J S Finer-Moore; G F Maley; L Hardy; F Maley; R M Stroud
Journal:  Biochemistry       Date:  1990-07-31       Impact factor: 3.162

3.  Crystal structure of Escherichia coli thymidylate synthase containing bound 5-fluoro-2'-deoxyuridylate and 10-propargyl-5,8-dideazafolate.

Authors:  D A Matthews; K Appelt; S J Oatley; N H Xuong
Journal:  J Mol Biol       Date:  1990-08-20       Impact factor: 5.469

4.  Improved methods for building protein models in electron density maps and the location of errors in these models.

Authors:  T A Jones; J Y Zou; S W Cowan; M Kjeldgaard
Journal:  Acta Crystallogr A       Date:  1991-03-01       Impact factor: 2.290

5.  Plastic adaptation toward mutations in proteins: structural comparison of thymidylate synthases.

Authors:  K M Perry; E B Fauman; J S Finer-Moore; W R Montfort; G F Maley; F Maley; R M Stroud
Journal:  Proteins       Date:  1990

6.  Human thymidylate synthase is in the closed conformation when complexed with dUMP and raltitrexed, an antifolate drug.

Authors:  J Phan; S Koli; W Minor; R B Dunlap; S H Berger; L Lebioda
Journal:  Biochemistry       Date:  2001-02-20       Impact factor: 3.162

7.  Calculation of protein extinction coefficients from amino acid sequence data.

Authors:  S C Gill; P H von Hippel
Journal:  Anal Biochem       Date:  1989-11-01       Impact factor: 3.365

8.  The crystal structure of thymidylate synthase from Pneumocystis carinii reveals a fungal insert important for drug design.

Authors:  A C Anderson; K M Perry; D M Freymann; R M Stroud
Journal:  J Mol Biol       Date:  2000-03-31       Impact factor: 5.469

9.  Crystal structure of thymidylate synthase A from Bacillus subtilis.

Authors:  K M Fox; F Maley; A Garibian; L M Changchien; P Van Roey
Journal:  Protein Sci       Date:  1999-03       Impact factor: 6.725

10.  The structural mechanism for half-the-sites reactivity in an enzyme, thymidylate synthase, involves a relay of changes between subunits.

Authors:  A C Anderson; R H O'Neil; W L DeLano; R M Stroud
Journal:  Biochemistry       Date:  1999-10-19       Impact factor: 3.162

View more
  28 in total

1.  Structural analyses of human thymidylate synthase reveal a site that may control conformational switching between active and inactive states.

Authors:  Dan Chen; Anna Jansson; Daniel Sim; Andreas Larsson; Pär Nordlund
Journal:  J Biol Chem       Date:  2017-06-20       Impact factor: 5.157

2.  Explaining an unusually fast parasitic enzyme: folate tail-binding residues dictate substrate positioning and catalysis in Cryptosporidium hominis thymidylate synthase.

Authors:  W Edward Martucci; Melissa A Vargo; Karen S Anderson
Journal:  Biochemistry       Date:  2008-08-02       Impact factor: 3.162

3.  The R163K mutant of human thymidylate synthase is stabilized in an active conformation: structural asymmetry and reactivity of cysteine 195.

Authors:  Lydia M Gibson; Leslie L Lovelace; Lukasz Lebioda
Journal:  Biochemistry       Date:  2008-03-28       Impact factor: 3.162

4.  Variants of human thymidylate synthase with loop 181-197 stabilized in the inactive conformation.

Authors:  Leslie L Lovelace; Saphronia R Johnson; Lydia M Gibson; Brittnaie J Bell; Sondra H Berger; Lukasz Lebioda
Journal:  Protein Sci       Date:  2009-08       Impact factor: 6.725

5.  Understanding the structural basis of species selective, stereospecific inhibition for Cryptosporidium and human thymidylate synthase.

Authors:  Daniel J Czyzyk; Margarita Valhondo; William L Jorgensen; Karen S Anderson
Journal:  FEBS Lett       Date:  2019-06-18       Impact factor: 4.124

6.  Mechanism of influence of phosphorylation on serine 124 on a decrease of catalytic activity of human thymidylate synthase.

Authors:  Adam Jarmuła; Tomasz Fraczyk; Piotr Cieplak; Wojciech Rode
Journal:  Bioorg Med Chem       Date:  2010-04-09       Impact factor: 3.641

7.  Structures of human thymidylate synthase R163K with dUMP, FdUMP and glutathione show asymmetric ligand binding.

Authors:  Lydia M Gibson; Lesa R Celeste; Leslie L Lovelace; Lukasz Lebioda
Journal:  Acta Crystallogr D Biol Crystallogr       Date:  2010-12-16

8.  Molecular docking studies on quinazoline antifolate derivatives as human thymidylate synthase inhibitors.

Authors:  Vivek Srivastava; Satya Prakash Gupta; Mohd Imran Siddiqi; Bhartendu Nath Mishra
Journal:  Bioinformation       Date:  2010-02-28

9.  Development and binding mode assessment of N-[4-[2-propyn-1-yl[(6S)-4,6,7,8-tetrahydro-2-(hydroxymethyl)-4-oxo-3H-cyclopenta[g]quinazolin-6-yl]amino]benzoyl]-l-γ-glutamyl-D-glutamic acid (BGC 945), a novel thymidylate synthase inhibitor that targets tumor cells.

Authors:  Anna Tochowicz; Sean Dalziel; Oliv Eidam; Joseph D O'Connell; Sarah Griner; Janet S Finer-Moore; Robert M Stroud
Journal:  J Med Chem       Date:  2013-06-21       Impact factor: 7.446

Review 10.  Ubiquitin-independent proteasomal degradation.

Authors:  Jenny Erales; Philip Coffino
Journal:  Biochim Biophys Acta       Date:  2013-05-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.